Last edition
News about "Biomoneta"
Biomoneta's Avata Rx Becomes First Indian Air-Decontamination Technology to Receive US FDA Approval
Biomoneta, a pioneering Indian healthtech company backed by Beyond Next Ventures India (BNV India), has secured approval from the US Food and Drug Administration (US FDA) for its flagship air-decontamination system, Avata Rx. This marks the first time an Indian company has received FDA clearance in the air-decontamination category.
Biomoneta | 03/12/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy